Denali Therapeutics, Inc. (DNLI)
22.28
-0.52
(-2.28%)
USD |
NASDAQ |
Sep 04, 16:00
22.28
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Research and Development Expense (Quarterly) : 97.02M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 97.02M |
| March 31, 2026 | 103.85M |
| December 31, 2025 | 97.90M |
| September 30, 2025 | 101.95M |
| June 30, 2025 | 102.70M |
| March 31, 2025 | 116.23M |
| December 31, 2024 | 99.79M |
| September 30, 2024 | 98.24M |
| June 30, 2024 | 91.40M |
| March 31, 2024 | 107.02M |
| December 31, 2023 | 107.80M |
| September 30, 2023 | 89.74M |
| June 30, 2023 | 97.52M |
| March 31, 2023 | 128.82M |
| December 31, 2022 | 92.11M |
| September 30, 2022 | 87.79M |
| June 30, 2022 | 92.74M |
| March 31, 2022 | 86.10M |
| December 31, 2021 | 67.88M |
| September 30, 2021 | 71.56M |
| Date | Value |
|---|---|
| June 30, 2021 | 65.71M |
| March 31, 2021 | 60.21M |
| December 31, 2020 | 54.74M |
| September 30, 2020 | 53.70M |
| June 30, 2020 | 53.15M |
| March 31, 2020 | 51.02M |
| December 31, 2019 | 51.55M |
| September 30, 2019 | 52.54M |
| June 30, 2019 | 50.08M |
| March 31, 2019 | 37.40M |
| December 31, 2018 | 39.91M |
| September 30, 2018 | 30.32M |
| June 30, 2018 | 44.23M |
| March 31, 2018 | 20.82M |
| December 31, 2017 | 17.66M |
| September 30, 2017 | 17.74M |
| June 30, 2017 | 19.00M |
| March 31, 2017 | 18.47M |
| December 31, 2016 | 16.04M |
| September 30, 2016 | 27.42M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 192.06M |
| Oncolytics Biotech, Inc. | 4.262M |
| Sangamo Therapeutics, Inc. | 26.57M |
| Sarepta Therapeutics, Inc. | 91.26M |
| Anixa Biosciences, Inc. | 1.258M |